U.S. market Closed. Opens in 1 day 4 hours 3 minutes

ATNM | Actinium Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Revenue81.00K1.03M1.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A699.00K524.00K447.00K420.09K50.72K55.94K77.52K53.47KN/A4.12KN/AN/AN/AN/AN/AN/AN/A
Gross Profit81.00K331.00K620.00K-447.00K-420.09K-50.72K-55.94K-77.52K-53.47KN/A-4.12KN/AN/AN/AN/AN/AN/AN/A
Operating Expenses52.00M35.13M26.11M22.39M22.07M23.83M26.91M26.85M24.83M22.48M6.59M7.95M9.62K25.41K14.54K26.42K11.99K17.53K
Selling, General & Admin13.33M12.00M8.08M6.31M5.52M6.73M9.16M9.27M11.46M10.18M3.92M4.51M9.62K25.41K14.54K18.92K11.01K17.53K
Research & Development38.67M23.14M18.03M16.09M16.55M17.09M17.70M17.50M13.31M12.27M2.67M3.44MN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/A55.94K77.52K53.47K37.91K1.56K581.00N/AN/AN/AN/A982.00N/A
Operating Income-51.92M-34.10M-24.96M-22.39M-22.07M-23.83M-26.91M-26.85M-24.83M-22.48M-6.59M-7.95M-9.95K-26.05K-16.02K-26.42K-11.99K-17.53K
Other Expenses / Income3.10M1.09M190.00K178.00K172.39K173.36K309.55K2.53M3.80M-2.21M-4.18M-413.91K20.24K27.73K-6.31K-4.73KN/AN/A
Before Tax Income-48.82M-33.02M-24.77M-22.21M-21.90M-23.65M-26.60M-24.32M-21.03M-24.69M-10.77M-8.36M10.29K1.67K-22.33KN/AN/AN/A
Income Tax ExpensesN/A-1.09M-190.00K-178.00K-172.39K173.36K-309.55K5.01K7.87K866.002.51K1.10M4.42K5.97K4.91K31.24K14.80K18.40K
Net Income-48.82M-31.93M-24.58M-22.04M-21.73M-23.65M-26.60M-24.32M-21.03M-24.69M-10.77M-8.36M10.29K1.67K-22.33K-31.24K-14.80K-18.40K
Interest ExpensesN/AN/AN/AN/AN/A173.36K5.43K5.01K7.87K866.002.51K1.10M4.76K6.62K6.40K4.82K2.81K870.00
Basic Shares Outstanding26.60M24.14M20.57M12.13M4.98M3.53M2.22M1.62M1.27M912.12K758.42K36.78K26.73K371.83K371.83K371.83K371.83K76.99K
Diluted Shares Outstanding26.60M24.14M20.57M12.13M4.98M3.53M2.22M1.62M1.27M912.12K758.42K36.78K26.73K371.83K371.83K371.83K371.83K76.99K
EBITDA-51.13M-33.41M-24.44M-21.77M-21.48M-23.78M-26.85M-26.77M-24.78M-22.44M-6.59M-7.95M15.05K8.29K-14.54K-26.32K-11.99K-17.53K
EBITDA Margin-63,123.46%-3,243.20%-2,136.36%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-48.82M-33.02M-24.77M-22.21M-21.90M-23.31M-26.91M-24.31M-21.01M-24.69M-10.77M-6.16M19.47K14.27K-11.02K4.82K2.81K870.00
EBIT Margin-60,269.14%-3,205.53%-2,165.56%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙